EFFICACY AND SAFETY OF EDARAVONE DEXBORNEOL FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE UNDERGOING ENDOVASCULAR THROMBECTOMY (TASTE-2): A MULTICENTER, DOUBLE-BLIND, PLACEBOCONTROLLED, RANDOMIZED CLINICAL TRIAL

被引：0

作者：

Wang, C. ^{[1
]}

Gu, H. ^{[1
]}

Huo, X. ^{[2
]}

Yuan, B. ^{[1
]}

Li, S. ^{[1
]}

Xu, J. ^{[1
]}

Jiang, Y. ^{[1
]}

Jing, J. ^{[1
]}

Yao, X. ^{[3
]}

Li, Z. ^{[1
,4
]}

Long, F. ^{[5
]}

Ma, Z. ^{[6
]}

Zhuang, X. ^{[7
]}

Xu, L. ^{[8
]}

Jin, Y. ^{[9
]}

Huang, W. ^{[10
]}

Zhang, Y. ^{[11
]}

Wen, J. ^{[12
]}

Wang, A. ^{[13
]}

Pan, Y. ^{[1
]}

Ye, W. ^{[1
]}

Yu, W. ^{[1
]}

Cheng, A. ^{[1
]}

Wang, M. ^{[1
]}

Dong, Q. ^{[14
]}

Xu, A. ^{[15
]}

Wang, N. ^{[16
]}

Yang, Y. ^{[17
]}

Meng, X. ^{[1
]}

Liu, L. ^{[1
]}

Zhao, X. ^{[1
]}

Li, H. ^{[1
]}

Miao, Z. ^{[1
]}

Li, Z. ^{[1
,4
]}

Wang, Y. ^{[18
]}

机构：

[1] Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China

[2] Capital Med Univ, Beijing Anzhen Hosp, Ctr Neurol Dis, Cerebrovasc Dis Dept, Beijing, Peoples R China

[3] First Peoples Hosp Chen Zhou City, Dept Neurol, Chenzhou, Peoples R China

[4] Peoples Hosp Huazhou, Huazhou, Peoples R China

[5] Second Affliated Hosp Hainan Med Univ, Haikou, Hainan, Peoples R China

[6] Suzhou Hosp Anhui Med Univ, Suzhou, Peoples R China

[7] Liaocheng Peoples Hosp, Liaocheng, Shandong, Peoples R China

[8] Cent Hosp Jiamusi City, Jiamusi, Heilongjiang, Peoples R China

[9] Peoples Hosp Bozhou, Bozhou, Peoples R China

[10] Maoming Hosp Guangzhou Univ Chinese Med, Maoming, Peoples R China

[11] First Peoples Hosp Wenling, Wenling, Peoples R China

[12] First Peoples Hosp Changde City, Changde, Peoples R China

[13] China Natl Clin Res Ctr Neurol Dis, Dept Stat, Beijing, Peoples R China

[14] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai, Peoples R China

[15] First Affiliated Hosp Jinan Univ, Guangzhou, Peoples R China

[16] First Affiliated Hosp Fujian Med Univ, Fuzhou, Peoples R China

[17] First Hosp Jilin Univ, Dept Neurol, Stroke Ctr, Changchun, Peoples R China

[18] Beijing Tiantan Hosp, Beijing, Peoples R China

来源：

INTERNATIONAL JOURNAL OF STROKE | 2024年 / 19卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

O127 / #3

引用

页码：58 / 58

页数：1

共 50 条

[1] Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke A Phase III, Randomized, Double-Blind, Comparative Trial
Xu, Jie
Wang, Anxin
Meng, Xia
Yalkun, Gulbahram
Xu, Anding
Gao, Zhiqiang
Chen, Huisheng
Ji, Yong
Xu, Jun
Geng, Deqin
Zhu, Runxiu
Liu, Bo
Dong, Aiqin
Mu, Hua
Lu, Zhihong
Li, Shuya
Zheng, Huaguang
Chen, Xia
Wang, Yilong
Zhao, Xingquan
Wang, Yongjun
STROKE, 2021, 52 (03) : 772 - 780
[2] Safety And Efficacy Of Edaravone Dexborneol Versus Edaravone Alone For The Treatment Of Acute Ischemic Stroke Patients With Hypertention: Analysis From Taste Trial
Xu, Jie
Wang, Yongjun
HYPERTENSION, 2021, 78
[3] Rationale and design of Treatment of Acute Ischaemic Stroke with Edaravone Dexborneol II (TASTE-2): a multicentre randomised controlled trial
Wang, Chunjuan
Gu, Hong-Qiu
Dong, Qiang
Xu, Anding
Wang, Ning
Yang, Yi
Wang, Feng
Wang, Yongjun
STROKE AND VASCULAR NEUROLOGY, 2024, 9 (06) : 730 - 737
[4] Combined Selective Endovascular Brain Hypothermia with Edaravone Dexborneol versus Edaravone Dexborneol Alone for Endovascular Treatment in Acute Ischemic Stroke (SHE): Protocol for a Multicenter, Single-Blind, Randomized Controlled Study
Jiang, Xin
Chen, Lizhang
Wang, Jian
Fang, Jinghuan
Ma, Mengmeng
Zhou, Muke
Zheng, Hongbo
Hu, Fayun
Zhou, Dong
He, Li
CEREBROVASCULAR DISEASES, 2024,
[5] Sublingual edaravone dexborneol for the treatment of acute ischemic stroke: the TASTE-SL randomized clinical trial (vol 81, pg 319, 2024)
Fu, Y.
Wang, A.
Tang, R.
JAMA NEUROLOGY, 2024, 81 (04) : 425 - 425
[6] A randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke
Sharma, Pawan
Sinha, Manish
Shukla, R.
Garg, R. K.
Verma, R.
Singh, M. K.
ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2011, 14 (02) : 103 - 106
[7] Efficacy and Safety of Mildronate for Acute Ischemic Stroke: A Randomized, Double-Blind, Active-Controlled Phase II Multicenter Trial
Zhu, Yi
Zhang, Guangyun
Zhao, Jun
Li, Deshuai
Yan, Xiaodong
Liu, Juanfang
Liu, Xuedong
Zhao, Haibo
Xia, Jielai
Zhang, Xiao
Li, Zhengyi
Zhang, Baorong
Guo, Zongcheng
Feng, Lianyuan
Zhang, Zhaodong
Qu, Fang
Zhao, Gang
CLINICAL DRUG INVESTIGATION, 2013, 33 (10) : 755 - 760
[8] Efficacy and Safety of Mildronate for Acute Ischemic Stroke: A Randomized, Double-Blind, Active-Controlled Phase II Multicenter Trial
Yi Zhu
Guangyun Zhang
Jun Zhao
Deshuai Li
Xiaodong Yan
Juanfang Liu
Xuedong Liu
Haibo Zhao
Jielai Xia
Xiao Zhang
Zhengyi Li
Baorong Zhang
Zongcheng Guo
Lianyuan Feng
Zhaodong Zhang
Fang Qu
Gang Zhao
Clinical Drug Investigation, 2013, 33 : 755 - 760
[9] Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial
Xu, Jie
Wang, Yilong
Wang, Anxin
Gao, Zhiqiang
Gao, Xiaoping
Chen, Huisheng
Zhou, Junshan
Zhao, Xingquan
Wang, Yongjun
STROKE AND VASCULAR NEUROLOGY, 2019, 4 (03) : 109 - 114
[10] Endovascular treatment for acute ischemic stroke: Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands (MR CLEAN)
Diener H.-C.
Nitschmann S.
Der Internist, 2015, 56 (7): : 847 - 850

← 1 2 3 4 5 →